Showing results (171-180 of 212) with videos related to

Sort By:
Pageof 22
The Lancet. Oncology|May 23, 2008
Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trialByeong-Ho Park, Taeho Hwang, Ta-Chiang Liu, et al.
Cancer|October 18, 2024
Phase 2 trial of avelumab in combination with gemcitabine in advanced leiomyosarcoma as a second-line treatment (EAGLES, Korean Cancer Study Group UN18-09)Miso Kim, Yu Jung Kim, Koung Jin Suh, et al.
Cancer Research and Treatment|July 16, 2024
Assessing the Efficacy of Bortezomib and Dexamethasone for Induction and Maintenance Therapy in Relapsed/Refractory Cutaneous T-Cell Lymphoma: A Phase II CISL1701/BIC StudyYoon Seok Choi, Joonho Shim, Ka-Won Kang, et al.
BMC Cancer|July 30, 2011
Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL)Seok Jin Kim, Chul Won Choi, Yeung-Chul Mun, et al.
Blood Research|October 19, 2017
Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trialJeongkuk Seo, Won Seog Kim, Jin Seok Kim, et al.
Leukemia & Lymphoma|September 29, 2015
A phase II study of oxaliplatin and prednisone for patients with relapsed or refractory marginal zone lymphoma: Consortium for Improving Survival of Lymphoma trialSung Yong Oh, Won Seog Kim, Jin Seok Kim, et al.
Blood|December 15, 2010
Comparison of treatment strategies for patients with intestinal diffuse large B-cell lymphoma: surgical resection followed by chemotherapy versus chemotherapy aloneSeok Jin Kim, Hye Jin Kang, Jin Seok Kim, et al.
Annals of Hematology|July 27, 2011
Clinical features and outcomes of Hodgkin's lymphoma in Korea: Consortium for Improving Survival of Lymphoma (CISL)Young-Woong Won, Jung Hye Kwon, Soon Il Lee, et al.
BMC Cancer|June 24, 2010
Clinical outcomes and prognostic factors in patients with breast diffuse large B cell lymphoma; Consortium for Improving Survival of Lymphoma (CISL) studyHo-Young Yhim, Hye Jin Kang, Yoon Hee Choi, et al.
Cancer Research and Treatment|April 13, 2023
A Multicenter, Prospective, Observational Study to Evaluate Ethanol-Induced Symptoms in Patients Receiving Docetaxel ChemotherapyYoung-Woong Won, Jin-Hyoung Kang, Jung Hye Kwon, et al.
Pageof 22